Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Other Accumulated Expenses (2016 - 2024)

Historic Other Accumulated Expenses for Firefly Neuroscience (AIFF) over the last 10 years, with Q2 2024 value amounting to $230024.0.

  • Firefly Neuroscience's Other Accumulated Expenses fell 5507.45% to $230024.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $230024.0, marking a year-over-year decrease of 5507.45%. This contributed to the annual value of $267604.0 for FY2023, which is 560.61% down from last year.
  • As of Q2 2024, Firefly Neuroscience's Other Accumulated Expenses stood at $230024.0, which was down 5507.45% from $168658.0 recorded in Q1 2024.
  • Firefly Neuroscience's 5-year Other Accumulated Expenses high stood at $816536.0 for Q1 2022, and its period low was $7656.0 during Q2 2020.
  • For the 5-year period, Firefly Neuroscience's Other Accumulated Expenses averaged around $274381.1, with its median value being $223566.0 (2023).
  • In the last 5 years, Firefly Neuroscience's Other Accumulated Expenses plummeted by 8630.22% in 2020 and then surged by 1004708.59% in 2022.
  • Firefly Neuroscience's Other Accumulated Expenses (Quarter) stood at $54274.0 in 2020, then surged by 276.02% to $204080.0 in 2021, then skyrocketed by 38.91% to $283497.0 in 2022, then dropped by 5.61% to $267604.0 in 2023, then decreased by 14.04% to $230024.0 in 2024.
  • Its Other Accumulated Expenses stands at $230024.0 for Q2 2024, versus $168658.0 for Q1 2024 and $267604.0 for Q4 2023.